600535:SHA
Tasly Pharmaceutical Group Co Ltd
CNÂ¥14.34
arrow_downward
-0.62%(-0.090) 1D
Nov 4, 3:00:02 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CNÂ¥14.43
High
CNÂ¥14.59
Low
CNÂ¥14.32
Mkt. cap
21.56B
Avg. vol.
12.45M
Volume
18.15M
Dividend
2.37%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 15, 2026
P/E ratio
17.51
52-wk high
CNÂ¥16.24
52-wk low
CNÂ¥12.90
EPS
CNÂ¥0.82
Shares outstanding
1.51B
No. of employees
11K
Open
CNÂ¥14.43
High
CNÂ¥14.59
Low
CNÂ¥14.32
Mkt. cap
21.56B
Avg. vol.
12.45M
Volume
18.15M
Dividend
2.37%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 15, 2026
P/E ratio
17.51
52-wk high
CNÂ¥16.24
52-wk low
CNÂ¥12.90
EPS
CNÂ¥0.82
Shares outstanding
1.51B
No. of employees
11K
Related stocks
News stories
From web sources and news partners
Virginia Business
·
1 hour ago
Accendra Health could be delisted by NYSE
Springfield News-Sun
·
6 minutes ago
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
Yahoo Finance
·
33 minutes ago
Expedia (NASDAQ:EXPE) posts better-than-expected sales in Q3 2026 but stock drops
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd